Zepbound is FDA-approved for obesity, while Mounjaro is approved to treat Type 2 diabetes
For Nausea and Vomiting: Antiemetic medications can provide relief
Jastreboff and colleagues (NEJM, 2023) reported substantial body-weight reduction in obesity research populations, and Rosenstock and colleagues (Lancet, 2023) documented glycemic and weight effects in type-2 diabetes research populations
Not only do they offer greater dosing flexibility, but they are also more accessible during shortages of brand-name medications
Hansford R, Buller S, Tsang AH, et al
The community allows you to post photos and videos of your journey, find and follow other people, take part in challenges and much more, all designed to help you reach your goals